About Wynclark Pharmaceuticals Private Limited
Data last updated: 01 January 2026
Wynclark Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Medplus Health Services Limited. It specialises in pharmaceutical retail and distribution, a part of the broader pharmaceuticals sector. Incorporated on 08 February 2007, the company has been in operation for over 19 years.
Registered with ROC Hyderabad under CIN U24239TG2007PTC052676.
Capital: an authorised share capital of ₹14.08 Cr and a paid-up capital of ₹14.08 Cr. Formerly known as Medplus Mart Global Private Limited and Medplus Smart Private Limited. It is led by directors including Paidiwar Srinivas and Bhaskar Reddy Cherukupalli.
Last AGM: 05 September 2025. Financial statements filed for year ended 31 March 2025. Office: Ground Floor 12 – 7 – 20/64/2 Survey No. 793 Goods Shed Road Moosapet Kukatpally, Hyderabad, Telangana, India – 500018.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.13 Cr, a decline of 70% compared to the previous year.
The company has a workforce of approximately 7 employees as per the latest available data. It operates as a subsidiary of Medplus Health Services Limited.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medplusindia.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Apps
-
Registered AddressGround Floor 12 – 7 – 20/64/2 Survey No. 793 Goods Shed Road Moosapet Kukatpally, Hyderabad, Telangana, India – 500018
-
IndustryPharma, Pharmaceutical Retailers & Distributors
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Wynclark Pharmaceuticals Private Limited
Wynclark Pharmaceuticals Private Limited has undergone 4 name changes throughout its history. The current legal name is Wynclark Pharmaceuticals Private Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Wynclark Pharmaceuticals Private Limited | Current |
| Medplus Mart Global Private Limited | Previous |
| Medplus Smart Private Limited | Previous |
| Medplus Pathlabs Private Limited | Previous |
| Medsupply Distributors Private Limited | Previous |
CIN History of Wynclark Pharmaceuticals Private Limited
Wynclark Pharmaceuticals Private Limited has one previous CIN (Corporate Identification Number): U24239AP2007PTC052676. The current CIN is U24239TG2007PTC052676, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2007PTC052676 | Current |
| U24239AP2007PTC052676 | Previous |
Business Activity of Wynclark Pharmaceuticals Private Limited
Wynclark Pharmaceuticals Private Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details for Wynclark Pharmaceuticals Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Wynclark Pharmaceuticals Private Limited
Wynclark Pharmaceuticals Private Limited is audited by Gphk & Associates for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Gphk & Associates | Locked | Locked | Locked |
Complete auditor history for Wynclark Pharmaceuticals Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors and KMP of Wynclark Pharmaceuticals Private Limited
Wynclark Pharmaceuticals Private Limited currently reports 3 directors and 1 key managerial person. 7 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Sujit Kumar Mahato
Also directs:
Optival Health Solutions Private Limited
|
Cfo | 16 Nov 2022 | 3 Years 7 Months | Current |
|
Paidiwar Srinivas
Also directs:
Dureleg Manufacturing Private Limited, Sai Sridhar Pharma Private Limited, Deccan Medisales Private Limited and 5 more
|
Director | 03 Aug 2013 | 12 Years 11 Months | Current |
|
Bhaskar Reddy Cherukupalli
Also directs:
Clearancekart Private Limited, Kalyani Meditimes Private Limited, Agilepro (India) Ventures Llp and 5 more
|
Director | 29 Sep 2021 | 4 Years 9 Months | Current |
|
Satya Murali Krishna Kammila
Also directs:
Dureleg Manufacturing Private Limited, Sai Sridhar Pharma Private Limited, Deccan Medisales Private Limited and 5 more
|
Whole-Time Director | 29 Sep 2021 | 4 Years 9 Months | Current |
Financials of Wynclark Pharmaceuticals Private Limited FY 2025 filings available
Wynclark Pharmaceuticals Private Limited reported revenue of ₹13.13 Cr (down 70.00% YoY) for FY 2025.
Ten-year financial statements for Wynclark Pharmaceuticals Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Wynclark Pharmaceuticals Private Limited
Shareholding and ownership data for Wynclark Pharmaceuticals Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings Wynclark Pharmaceuticals Private Limited
Wynclark Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Wynclark Pharmaceuticals Private Limited
Wynclark Pharmaceuticals Private Limited has a workforce of 7 employees as of Apr 10, 2024.
Employee and EPFO history for Wynclark Pharmaceuticals Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Wynclark Pharmaceuticals Private Limited
GST registrations and filing compliance for Wynclark Pharmaceuticals Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Wynclark Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts for Wynclark Pharmaceuticals Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Wynclark Pharmaceuticals Private Limited
MSME payment history for Wynclark Pharmaceuticals Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Wynclark Pharmaceuticals Private Limited
Corporate group structure for Wynclark Pharmaceuticals Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Wynclark Pharmaceuticals Private Limited
MCA filings and documents for Wynclark Pharmaceuticals Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Wynclark Pharmaceuticals Private Limited
Frequently Asked Questions about Wynclark Pharmaceuticals Private Limited
Wynclark Pharmaceuticals Private Limited is an active private limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 08 February 2007 (19+ years old) and is registered under CIN U24239TG2007PTC052676. The company has 7 employees.
Wynclark Pharmaceuticals Private Limited reported revenue of ₹13.13 Cr for FY 2025 (down 70.00% YoY).
The current directors and KMP of Wynclark Pharmaceuticals Private Limited are:
- Sujit Kumar Mahato - Cfo
- Paidiwar Srinivas - Director
- Bhaskar Reddy Cherukupalli - Director
- Satya Murali Krishna Kammila - Whole-Time Director
The primary industry of Wynclark Pharmaceuticals Private Limited is pharma. The company specifically operates in pharmaceutical retailers and distributors. The company is currently active in this sector.
Wynclark Pharmaceuticals Private Limited can be reached at the registered office: Ground Floor 12 – 7 – 20642 Survey No. 793 Goods Shed Road Moosapet Kukatpally, Hyderabad, Telangana, India – 500018, or through the website medplusindia.com.
The authorised capital is ₹14.08 Cr, and the paid-up capital is ₹14.08 Cr.